BioCentury | Jun 18, 2007
Company News

Alphagenics Diaco Biotechnologies s.r.l., Grant Life Sciences deal

GLIF received rights to manufacture and market Alphagenics's molecular diagnostic test for human papillomavirus (HPV). The rights are exclusive in the U.S. and Greater China and non-exclusive in Europe, India, Australia and Japan. GLIF expects...
BioCentury | Sep 30, 2002
Company News

Aradigm, geneRx+ Inc. deal

ARDM will conduct preclinical studies and assess the potential of using its AERx pulmonary technology to deliver geneRx+'s two drug candidates, Alphagen and Coxagen, for hereditary emphysema and pulmonary hypertension, respectively. ARDM is eligible to...
BioCentury | May 20, 2002
Company News

AlphaGene genomics, bioinformatics news

...a buyer. Last fall, the company enlisted UBS Warburg in efforts to seek strategic alternatives. AlphaGene Inc....
BioCentury | Jan 14, 2002
Finance

Hat in Hand?

...Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics $10.0M Proteome Inc. $8.1M Targesome $7.5M AlphaGene...
BioCentury | Nov 19, 2001
Company News

AlphaGene, Celera Genomics Group deal

...AlphaGene granted CRA distribution rights to its collection of human full-length genes. AlphaGene will isolate, sequence...
...through its Celera Discovery System database of genome and biological data sets and computational tools. AlphaGene Inc....
BioCentury | Nov 13, 2001
Company News

Celera, AlphaGene gene distribution deal

...AlphaGene granted CRA distribution rights to its collection of human full-length genes. AlphaGene will isolate, sequence...
BioCentury | Sep 17, 2001
Company News

AlphaGene, Wayne State University deal

...and to correlate the expression patterns with treatment regimens to develop diagnostic and prognostic tools. AlphaGene Inc....
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics $10.0M Proteome $8.1M Targesome $7.5M AlphaGene...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics $10.0M Proteome $8.1M Targesome $7.5M AlphaGene...
BioCentury | Jul 16, 2001
Company News

AlphaGene, Lahey Clinic deal

...prostate CEA splice variants and their relationship to various stages of disease. The deal combines AlphaGene's...
...gene and microarray and bioinformatics platforms with the clinic's tissue, serum and metastatic tissue samples. AlphaGene Inc....
Items per page:
1 - 10 of 36
BioCentury | Jun 18, 2007
Company News

Alphagenics Diaco Biotechnologies s.r.l., Grant Life Sciences deal

GLIF received rights to manufacture and market Alphagenics's molecular diagnostic test for human papillomavirus (HPV). The rights are exclusive in the U.S. and Greater China and non-exclusive in Europe, India, Australia and Japan. GLIF expects...
BioCentury | Sep 30, 2002
Company News

Aradigm, geneRx+ Inc. deal

ARDM will conduct preclinical studies and assess the potential of using its AERx pulmonary technology to deliver geneRx+'s two drug candidates, Alphagen and Coxagen, for hereditary emphysema and pulmonary hypertension, respectively. ARDM is eligible to...
BioCentury | May 20, 2002
Company News

AlphaGene genomics, bioinformatics news

...a buyer. Last fall, the company enlisted UBS Warburg in efforts to seek strategic alternatives. AlphaGene Inc....
BioCentury | Jan 14, 2002
Finance

Hat in Hand?

...Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics $10.0M Proteome Inc. $8.1M Targesome $7.5M AlphaGene...
BioCentury | Nov 19, 2001
Company News

AlphaGene, Celera Genomics Group deal

...AlphaGene granted CRA distribution rights to its collection of human full-length genes. AlphaGene will isolate, sequence...
...through its Celera Discovery System database of genome and biological data sets and computational tools. AlphaGene Inc....
BioCentury | Nov 13, 2001
Company News

Celera, AlphaGene gene distribution deal

...AlphaGene granted CRA distribution rights to its collection of human full-length genes. AlphaGene will isolate, sequence...
BioCentury | Sep 17, 2001
Company News

AlphaGene, Wayne State University deal

...and to correlate the expression patterns with treatment regimens to develop diagnostic and prognostic tools. AlphaGene Inc....
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics $10.0M Proteome $8.1M Targesome $7.5M AlphaGene...
BioCentury | Aug 27, 2001
Finance

Money Hunters

...$12.0M Pharmadigm $12.0M Metabolex $10.8M GeneMachines $10.7M Maxia $10.0M eBioinformatics $10.0M Proteome $8.1M Targesome $7.5M AlphaGene...
BioCentury | Jul 16, 2001
Company News

AlphaGene, Lahey Clinic deal

...prostate CEA splice variants and their relationship to various stages of disease. The deal combines AlphaGene's...
...gene and microarray and bioinformatics platforms with the clinic's tissue, serum and metastatic tissue samples. AlphaGene Inc....
Items per page:
1 - 10 of 36